NasdaqGS:AMLXPharmaceuticals
A Look At Amylyx Pharmaceuticals (AMLX) Valuation After Recent Share Price Volatility
Why Amylyx Pharmaceuticals Stock Is On Investors’ Radar
Amylyx Pharmaceuticals (AMLX) has drawn fresh attention after recent trading saw the stock down about 4% on the day, extending declines of roughly 10% over the past week and 22% over the past month.
For investors tracking biotech volatility, this short term pullback sits against a longer backdrop where Amylyx Pharmaceuticals shows a year to date gain of about 16% and a 1 year total return near 174%, paired with a 3 year total return...